DSIP
DSIP
Also known as: DSIP Recovery Peptide, Delta Sleep Peptide
Overview
Key Facts
Primary Goal: A nonapeptide originally isolated from rabbit brain that promotes deep delta-wave sleep
A nonapeptide originally isolated from rabbit brain that promotes deep delta-wave sleep. Increasingly recognized for its role in recovery through improved sleep architecture, stress modulation, and hormonal regulation. Half-Life ~15 minutes (rapid enzymatic degradation) Typical Dose 100–300 mcg Frequency 1x daily before bed Cycle Length 2-4 weeks, cycling on/off
Dosing Information
Half-Life
~15 minutes (rapid enzymatic degradation)
Typical Dose
100–300 mcg
Frequency
1x daily before bed
Cycle Length
2-4 weeks, cycling on/off
Administration Routes:
Storage & Reconstitution
Unreconstituted (Powder)
Reconstituted (Mixed)
Note: Protect from light. Do not freeze reconstituted solution.
Research Summary
Discovered in 1977 by Schoenenberger and Monnier. Studied in human trials for insomnia, chronic pain, and withdrawal syndromes with mixed but promising results. Most research from 1980s-1990s European studies. Mechanism remains complex and not fully elucidated.
Frequently Asked Questions
Common questions about DSIP
UK-Specific Information
Exclusive data points and guidance for UK residents using DSIP
UK Lab Testing
US Lab Testing
Recommended labs: Quest Diagnostics, LabCorp ($120-$200 for peptide safety panel)
Why this matters: UK-specific lab testing guidance not available on US competitor sites
Commonly Stacked With
5-Amino-1MQ
Research and therapeutic applications of 5-Amino-1MQ
Ac-SDKP
Research and therapeutic applications of Ac-SDKP
ACE-031
Research and therapeutic applications of ACE-031
Acetyl Hexapeptide-3
Research and therapeutic applications of Acetyl Hexapeptide-3
AHK-Cu
Research and therapeutic applications of AHK-Cu
Alcohol Prep Pads
Research and therapeutic applications of Alcohol Prep Pads
Note: Peptide stacking should only be done under the guidance of a qualified healthcare professional. Individual responses may vary.